MediWound Ltd.
MDWD- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001593984
In the last 90 days, MediWound Ltd. insiders filed 1 open-market purchase and 2 sales; 78 institutions reported holding it in 13F filings for Q2 2026, worth $85.5M in total; ARK Invest is the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding MediWound Ltd. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 64 | +2 |
| Shares | 4.21M | 10.6K | 4.43M | +237.6K (+5.7%) |
| Value | $76.0M | $191.3K | $79.0M | +$3.18M (+4.2%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held MediWound Ltd. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| We Are One Seven, LLC | 12,158 | $216.4K | 0.01% |
| R Squared Ltd | 1,810 | $32.2K | 0.03% |
| Police & Firemen's Retirement System of New Jersey | 1,610 | $28.7K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,053 | $18.7K | 0.00% |
| Geneos Wealth Management Inc. | 215 | $3.83K | 0.00% |
| Steward Partners Investment Advisory, LLC | 42 | $748 | 0.00% |
| EverSource Wealth Advisors, LLC | 2 | $36 | 0.00% |
Sold out (5)
Institutions that held MediWound Ltd. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| EAM Investors, LLC | 32,783 | $592.1K |
| Point72 Asset Management, L.P. | 11,727 | $211.8K |
| Acadian Asset Management LLC | 2,452 | $44.0K |
| Stone House Investment Management, LLC | 500 | $9.03K |
| Citadel Advisors LLC | 23 | $415 |
Not filed for Q4 2024 yet (1)
Institutions that held MediWound Ltd. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 10,593 | $191.3K |